Patient-centered Information on Permanent Contraception
Launched by UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · Feb 29, 2024
Trial Information
Current as of July 24, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is looking to see if providing women with more information about two types of permanent birth control—tubal sterilization and long-acting reversible contraception (like IUDs)—can help them feel more confident about their choices. The study focuses on women who really want to avoid future pregnancies and are interested in learning more about their options. Participants will answer some questions at the beginning, explore a new educational website that compares these two methods, and then share their thoughts in follow-up surveys at two different times: right after visiting the site and again three months later.
To be eligible for this trial, women should be between the ages of 18 and 45, should not be currently pregnant, and should be fluent in English or Spanish. They should also have a strong desire to prevent future pregnancies and should not have had a tubal sterilization procedure before. This study is currently recruiting participants, and it's a great opportunity for women looking to make informed decisions about their reproductive health.
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • Self-reported fertility
- • Have a strong desire to avoid future pregnancy
- • Speak English or Spanish
- Exclusion Criteria:
- • Current pregnancy
- • The inability to speak English or Spanish
- • Prior tubal sterilization or "Essure" procedure
- • Menopause
- • Infertility
- • Hysterectomy
About University Of California, San Francisco
The University of California, San Francisco (UCSF) is a leading academic institution renowned for its commitment to advancing healthcare through innovative research and clinical trials. With a focus on translating scientific discoveries into effective therapies, UCSF collaborates with a diverse array of stakeholders, including healthcare professionals, industry partners, and patient communities. The university's research programs emphasize interdisciplinary approaches and leverage cutting-edge technology to address complex medical challenges. As a sponsor of clinical trials, UCSF is dedicated to maintaining the highest standards of ethical conduct and scientific rigor, ensuring the safety and well-being of participants while contributing to the broader medical knowledge base.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
San Francisco, California, United States
Patients applied
Trial Officials
Eleanor Schwarz, MD, MS
Principal Investigator
University of California, San Francisco
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported